Drug Shortage Report for TEVA-CANDESARTAN

Last updated on 2024-12-19 History
Report ID 220267
Drug Identification Number 02366320
Brand name TEVA-CANDESARTAN
Common or Proper name TEVA-CANDESARTAN 16MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CANDESARTAN CILEXETIL
Strength(s) 16MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes PP30
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-20
Estimated end date 2025-03-10
Actual end date 2024-12-18
Shortage status Resolved
Updated date 2024-12-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2024-12-19 French Compare
v34 2024-12-19 English Compare
v33 2024-12-13 French Compare
v32 2024-12-13 English Compare
v31 2024-12-04 English Compare
v30 2024-12-02 French Compare
v29 2024-12-02 English Compare
v28 2024-11-28 French Compare
v27 2024-11-28 English Compare
v26 2024-11-21 French Compare
v25 2024-11-21 English Compare
v24 2024-11-18 French Compare
v23 2024-11-18 English Compare
v22 2024-11-08 French Compare
v21 2024-11-08 English Compare
v20 2024-10-11 French Compare
v19 2024-10-11 English Compare
v18 2024-10-11 French Compare
v17 2024-10-11 English Compare
v16 2024-09-19 French Compare

Showing 1 to 20 of 35